We observed a significant increase in the number of stromal CD163+ TAMs with higher tumor stages, regardless of whether TNM (q = 0.04, Benjamini–Hochberg corrected Fisher exact test) or FIGO classifications (q = 0.001) were used (Table 2). Here, CD163 is linked to neoplasm.